title: Expansion of chemical space for collaborative lead generation and drug discovery: the European Lead Factory Perspective.
abstract: High-throughput screening (HTS) represents a major cornerstone of drug discovery. The availability of an innovative, relevant and high-quality compound collection to be screened often dictates the final fate of a drug discovery campaign. Given that the chemical space to be sampled in research programs is practically infinite and sparsely populated, significant efforts and resources need to be invested in the generation and maintenance of a competitive compound collection. The European Lead Factory (ELF) project is addressing this challenge by leveraging the diverse experience and know-how of academic groups and small and medium enterprises (SMEs) engaged in synthetic and/or medicinal chemistry. Here, we describe the novelty, diversity, structural complexity, physicochemical characteristics and overall attractiveness of this first batch of ELF compounds for HTS purposes.
authors.affiliation: Taros Chemicals GmbH & Co. KG, Emil-Figge-Str. 76a, 44227 Dortmund, Germany.
authors.forename: Anna
authors.initials: A
authors.lastname: Karawajczyk
authors.affiliation: Taros Chemicals GmbH & Co. KG, Emil-Figge-Str. 76a, 44227 Dortmund, Germany.
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Giordanetto
authors.affiliation: Mercachem, Kerkenbos 1013, 6546 BB Nijmegen, The Netherlands.
authors.forename: Jorg
authors.initials: J
authors.lastname: Benningshof
authors.affiliation: Sygnature Discovery, BioCity, Nottingham NG1 1GF, UK.
authors.forename: Daniel
authors.initials: D
authors.lastname: Hamza
authors.affiliation: Lead Discovery Center GmbH, Otto-Hahn-Strabe 15, 44227 Dortmund, Germany.
authors.forename: Tuomo
authors.initials: T
authors.lastname: Kalliokoski
authors.affiliation: Syncom BV, Kadijk 3, 9747 AT Groningen, The Netherlands.
authors.forename: Kees
authors.initials: K
authors.lastname: Pouwer
authors.affiliation: Edelris, 115, Avenue Lacassagne, F-69003 Lyon, France.
authors.forename: Remy
authors.initials: R
authors.lastname: Morgentin
authors.affiliation: School of Chemistry, University of Leeds, Leeds LS2 9JT, UK; Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK.
authors.forename: Adam
authors.initials: A
authors.lastname: Nelson
authors.affiliation: Mercachem, Kerkenbos 1013, 6546 BB Nijmegen, The Netherlands.
authors.forename: Gerhard
authors.initials: G
authors.lastname: Müller
authors.affiliation: Taros Chemicals GmbH & Co. KG, Emil-Figge-Str. 76a, 44227 Dortmund, Germany.
authors.forename: Alexander
authors.initials: A
authors.lastname: Piechot
authors.affiliation: Taros Chemicals GmbH & Co. KG, Emil-Figge-Str. 76a, 44227 Dortmund, Germany. Electronic address: dtzalis@taros.de.
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Tzalis
mesh_terms: D002626:Chemistry, Pharmaceutical / Q000379:methods; D003299:Cooperative Behavior; D015195:Drug Design; D055808:Drug Discovery / Q000379:methods*; D005060:Europe; D057166:High-Throughput Screening Assays / Q000379:methods*; D006801:Humans